OFFICIAL PUBLICATION OF

by its subsidiary APPco

API: Exclusive supply still a ‘very big issue’

Sheshtyn Paola 26/09/2018

The CEO of one of Australia’s leading pharmaceutical distributors says he wishes a solution had been organised “yesterday” Exclusive supply of medicines is still a “very big issue”, says Richard Vincent, CEO and Managing Director of Australian Pharmaceutical Industries (API) and Deputy Chairman of the National Pharmaceutical Services Association (NPSA), which represents Australian pharmaceutical wholesalers.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

API: Exclusive supply still a ‘very big issue’

Previous This sporting life

Next How the profession celebrated

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous This sporting life

Next How the profession celebrated

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.